The local hydrophobicity around tryptophan and was assessed by performing a second derivative on the Ultraviolet and Visible (UV/Vis) spectra and interpolating the resulting data. An interpolated derivative spectrum is shown in Supplementary Figure S1 . The spectrum is annotated with the tryptophan minimum, the a-value, and the b-value. The a and b values are used for calculating the a/b-ratio by dividing the former through the latter.
Supplementary Material B: Reversed-phase Chromatography
The purity of the stock solutions was assessed by reverse-phase chromatography based on the absorbance of the eluting species at 280 nm. The stock solutions were analyzed with a Waters Acquity BEH300 C4 1.7 µm column (Waters Corporation, Milford, US) on an Ultimate 3000 RS Ultra High Performance Liquid Chromatography (UHPLC) system consisting of a Pump HPG-3400RS, an Autosampler WPS-3000TFC, a Column Compartment TCC-3000RS, and a Diode Array Detector DAD-3000 controlled by Chromeleon version 6.8 SR15 (all Thermo Fisher Scientific, Waltham, US). The run duration was 6.8 min with a flow rate of 0.45 mL/min at a temperature of 80
• C with solvent A as 0.1% TFA in water and solvent B as 0.1% TFA in acetonitrile. Equilibration was done at 5% B, and a gradient of 4.7 min was run from 23.5% to 63.5% B. The column was stripped with 95% B for 0.5 min and then reequilibrated at 5% B for 1.3 min. 2 µL were injected for each analysis. Samples were analyzed in triplicates. The purity of the stock solutions was calculated as the percentage of absorbance at 280 nm of the respective Hepatitis B core Antigen (HBcAg) construct of the total absorbance of all eluting species.
Supplementary Material C: Cross-Flow Filtration (CFF) Process Progress
For interested readers, the permeate mass over time of the different processes is shown in Supplementary Figure S2 . 
